PRISM BioLab Completes Successful Tokyo IPO On Back Of Multiple Partnerships
Raises $11.5m
The Japanese drug discovery bioventure builds on multiple alliances and an in-house platform to get away a successful IPO in Tokyo, which it will use to fund further pipeline and technology development.
